The University of Southampton
University of Southampton Institutional Repository

Alpha-synuclein deficiency in the C57BL/6JOlaHsd strain does not modify disease progression in the ME7-model of prion disease

Asuni, A.A., Hilton, K., Siskova, Z., Lunnon, K., Reynolds, R., Perry, V.H. and O'Connor, V. (2010) Alpha-synuclein deficiency in the C57BL/6JOlaHsd strain does not modify disease progression in the ME7-model of prion disease Neuroscience, 165, (3), pp. 662-674.

Record type: Article


We previously detailed how intrahippocampal inoculation of C57BL/6J mice with murine modified scrapie (ME7) leads to chronic neurodegeneration (Cunningham C, Deacon R, Wells H, Boche D, Waters S, Diniz CP, Scott H, Rawlins JN, Perry VH (2003) Eur J Neurosci 17:2147–2155.). Our characterization of the ME7-model is based on inoculation of this murine modified scrapie agent into C57BL/6J mice from Harlan laboratories. This agent in the C57BL/6J host generates a disease that spans a 24-week time course. The hippocampal pathology shows progressive misfolded prion (PrPSc) deposition, astrogliosis and leads to behavioural dysfunction underpinned by the early synaptic loss that precedes neuronal death. The Harlan C57BL/6J, although widely used as a wild type mouse, are a sub-strain harbouring a spontaneous deletion of ?-synuclein with the full description C57BL/6JOlaHsd. Recently ?-synuclein has been shown to ameliorate the synaptic loss in a mouse model lacking the synaptic chaperone CSP-?. This opens a potential confound of the ME7-model, particularly with respect to the signature synaptic loss that underpin the physiological and behavioural dysfunction. To investigate if this strain-selective loss of a candidate disease modifier impacts on signature ME7 pathology, we compared cohorts of C57BL/6JOlaHsd (?-synuclein negative) with the founder strain from Charles Rivers (C57BL/6JCrl, ?-synuclein positive). There were subtle changes in behaviour when comparing control animals from the two sub-strains indicating potentially significant consequences for studies assuming neurobiogical identity of both strains. However, there was no evidence that the absence of ?-synuclein modifies disease. Indeed, accumulation of PrPSc, synaptic loss and the behavioural dysfunction associated with the ME7-agent was the same in both genetic backgrounds. Our data suggest that ?-synuclein deficiency does not contribute to the compartment specific processes that give rise to prion disease mediated synaptotoxicity and neurodegeneration.

Full text not available from this repository.

More information

Published date: 2010
Additional Information: Behavioural Neuroscience
Keywords: C57BL/6JCrl, C57BL/6JOlaHsd, neurodegeneration, synaptopathy, spontaneous-deletion


Local EPrints ID: 79987
ISSN: 0306-4522
PURE UUID: 5fabbbc9-b1fb-4b06-817c-61da250cfd91

Catalogue record

Date deposited: 23 Mar 2010
Last modified: 08 Oct 2017 22:12

Export record


Author: A.A. Asuni
Author: K. Hilton
Author: Z. Siskova
Author: K. Lunnon
Author: R. Reynolds
Author: V.H. Perry
Author: V. O'Connor

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton:

ePrints Soton supports OAI 2.0 with a base URL of

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.